Both oAd/APP and oAd/APP+DC treatment induced higher level of CD4- or CD8-positive T cell infiltration into tumor tissues than PBS or DC treatment, with oAd/APP+DC leading to more robust infiltration than oAd/APP monotherapy. The gene discussed is CD8A; the disease is neoplasm.